Cargando…
Tripterygium glycosides sensitizes cisplatin chemotherapeutic potency by modulating gut microbiota in epithelial ovarian cancer
Epithelial ovarian cancer (EOC) is a fatal gynecological malignancy with limited therapeutic options. Previous research has demonstrated that Tripterygium glycosides (GTW) can enhance effectiveness of cisplatin (DDP) chemotherapy against EOC. However, the underlying mechanism of GTW alleviating EOC...
Autores principales: | Zhan, Xinlu, Zuo, Qi, Huang, Genhua, Qi, Zhanghua, Wang, Yufan, Zhu, Sihong, Zhong, Yanying, Xiong, Yifei, Chen, Tingtao, Tan, Buzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560985/ https://www.ncbi.nlm.nih.gov/pubmed/37818040 http://dx.doi.org/10.3389/fcimb.2023.1236272 |
Ejemplares similares
-
Revealing the Disturbed Vaginal Micobiota Caused by Cervical Cancer Using High-Throughput Sequencing Technology
por: Xie, Yupei, et al.
Publicado: (2020) -
Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT
por: Huang, Genhua, et al.
Publicado: (2019) -
Glycyrrhizic acid glycosides reduces extensive tripterygium glycosides-induced lipid deposition in hepatocytes
por: Yang, Yifei, et al.
Publicado: (2023) -
GTW inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer via ILK/AKT/GSK3β/Slug Signalling Pathway
por: Feng, Ying, et al.
Publicado: (2021) -
Wells Syndrome Successfully Treated with Tripterygium Glycosides
por: Lu, Jiejie, et al.
Publicado: (2021)